Plasbumin
- Product NDC
- 13533-692
- 11-digit product format
- 135330692
- Labeler code
- 13533
- Product ID
- 13533-692_38864ce1-9eaf-4d04-bfca-39205b0f1504
- Type
- PLASMA DERIVATIVE
- Nonproprietary name
- Albumin (Human)
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- GRIFOLS USA, LLC
- Application
- BLA101138
- Marketing category
- BLA
- Marketing start
- 1994-09-26
- Substance
- ALBUMIN HUMAN
- Active strength
- 5 g/20mL
- Pharmacologic classes
- Human Serum Albumin [EPC], Increased Intravascular Volume [PE], Increased Oncotic Pressure [PE], Osmotic Activity [MoA], Serum Albumin [Chemical/Ingredient]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Plasbumin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ALBUMIN HUMAN | 5 g/20mL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13533-692-16 | Plasbumin | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 13533-692-17 | Plasbumin | 20 mL in 1 VIAL | SOLUTION | 20 | 16 | |
| 13533-692-20 | Plasbumin | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 13533-692-21 | Plasbumin | 50 mL in 1 VIAL | SOLUTION | 50 | 16 | |
| 13533-692-71 | Plasbumin | 1 in 1 CARTON | SOLUTION | 1 | 16 | |
| 13533-692-72 | Plasbumin | 100 mL in 1 VIAL | SOLUTION | 100 | 16 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13533-692-16 | ML - Milliliter | 13533-692 | 879169b7-b15a-4b85-9f43-309c9b3d4fd2 | 1 | 2012-07-24 |
| 13533-692-17 | ML - Milliliter | 13533-692 | abb8f58f-0947-4d56-8b36-e0fb2291fe38 | 1 | 2013-11-04 |
| 13533-692-20 | ML - Milliliter | 13533-692 | f5ecfe01-ff31-4168-9b40-f3eec4f7aed2 | 1 | 2012-07-24 |
| 13533-692-21 | ML - Milliliter | 13533-692 | d1a2e8d6-d370-482b-862b-656bc8be1630 | 1 | 2013-11-04 |
| 13533-692-71 | ML - Milliliter | 13533-692 | 54592db4-e02f-4770-b56c-b4cf82909ec5 | 1 | 2012-07-24 |
| 13533-692-72 | ML - Milliliter | 13533-692 | fa2203d9-85d1-44c3-b26b-d931417bde71 | 1 | 2013-11-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Albumin (human) | ACTIVE INGREDIENT | ZIF514RVZR | PLASBUMIN (ALBUMIN (HUMAN)) SOLUTION [GRIFOLS USA, LLC] | 8 | |
| Albumin (human) | ACTIVE MOIETY | ZIF514RVZR | PLASBUMIN (ALBUMIN (HUMAN)) SOLUTION [GRIFOLS USA, LLC] | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1741380 | albumin human 25 % in 100 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741570 | albumin human 25 % in 20 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741375 | albumin human 25 % in 50 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742399 | Plasbumin 25 % in 100 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742400 | Plasbumin 25 % in 20 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742395 | Plasbumin 25 % in 50 ML Injection | PSN | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742399 | 100 ML albumin human, USP 250 MG/ML Injection [Plasbumin] | SBD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742400 | 20 ML albumin human, USP 250 MG/ML Injection [Plasbumin] | SBD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742395 | 50 ML albumin human, USP 250 MG/ML Injection [Plasbumin] | SBD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741380 | 100 ML albumin human, USP 250 MG/ML Injection | SCD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741570 | 20 ML albumin human, USP 250 MG/ML Injection | SCD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741375 | 50 ML albumin human, USP 250 MG/ML Injection | SCD | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741375 | albumin human 12.5 GM per 50 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741380 | albumin human 25 % per 100 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741570 | albumin human 25 % per 20 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741375 | albumin human 25 % per 50 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741380 | albumin human 25 GM per 100 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1741570 | albumin human 5 GM per 20 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742395 | Plasbumin 12.5 GM per 50 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742399 | Plasbumin 25 % per 100 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742400 | Plasbumin 25 % per 20 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742395 | Plasbumin 25 % per 50 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742399 | Plasbumin 25 GM per 100 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
| 1742400 | Plasbumin 5 GM per 20 ML Injection | SY | 2eeb6b69-2013-c0a2-5e2f-0365114d41b4 | 16 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 13533-692-16 | 13533069216 | 1 VIAL in 1 CARTON (13533-692-16) / 20 mL in 1 VIAL (13533-692-17) | 1 vial | 1994-09-26 | 0000-00-00 | No | No | Current |
| 13533-692-17 | 13533069217 | 20 mL in 1 VIAL | 20 ml | Historical | ||||
| 13533-692-20 | 13533069220 | 1 VIAL in 1 CARTON (13533-692-20) / 50 mL in 1 VIAL (13533-692-21) | 1 vial | 1994-09-26 | 0000-00-00 | No | No | Current |
| 13533-692-21 | 13533069221 | 50 mL in 1 VIAL | 50 ml | Historical | ||||
| 13533-692-71 | 13533069271 | 1 VIAL in 1 CARTON (13533-692-71) / 100 mL in 1 VIAL (13533-692-72) | 1 vial | 1994-09-26 | 0000-00-00 | No | No | Current |
| 13533-692-72 | 13533069272 | 100 mL in 1 VIAL | 100 ml | Historical |